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Abstract 
Background: Yarrowia lipolytica, an oleaginous yeast, is a promising platform strain for production of biofuels 
and oleochemicals as it can accumulate a high level of lipids in response to nitrogen limitation. Accordingly, many 
metabolic engineering efforts have been made to develop engineered strains of Y. lipolytica with higher lipid yields. 
Genome‑scale model of metabolism (GEM) is a powerful tool for identifying novel genetic designs for metabolic 
engineering. Several GEMs for Y. lipolytica have recently been developed; however, not many applications of the GEMs 
have been reported for actual metabolic engineering of Y. lipolytica. The major obstacle impeding the application of Y. 
lipolytica GEMs is the lack of proper methods for predicting phenotypes of the cells in the nitrogen‑limited condition, 
or more specifically in the stationary phase of a batch culture.
Results: In this study, we showed that environmental version of minimization of metabolic adjustment (eMOMA) can 
be used for predicting metabolic flux distribution of Y. lipolytica under the nitrogen‑limited condition and identifying 
metabolic engineering strategies to improve lipid production in Y. lipolytica. Several well‑characterized overexpression 
targets, such as diglyceride acyltransferase, acetyl‑CoA carboxylase, and stearoyl‑CoA desaturase, were successfully 
rediscovered by our eMOMA‑based design method, showing the relevance of prediction results. Interestingly, the 
eMOMA‑based design method also suggested non‑intuitive knockout targets, and we experimentally validated the 
prediction with a mutant lacking YALI0F30745g, one of the predicted targets involved in one‑carbon/methionine 
metabolism. The mutant accumulated 45% more lipids compared to the wild‑type.
Conclusion: This study demonstrated that eMOMA is a powerful computational method for understanding and 
engineering the metabolism of Y. lipolytica and potentially other oleaginous microorganisms.
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Background
In recent years, environmental crises caused by mas-
sive use of fossil fuels raise urgent needs for develop-
ing renewable ways to produce fuels and chemicals. 
One of the promising solutions is a use of heterotrophic 
oleaginous microorganisms to produce lipid feedstocks 
for biofuels and oleochemicals [1, 2]. Production of 
lipids using heterotrophic oleaginous microorganisms 
has several advantages over competing strategies such 
as robustness of process, easiness of scale-up, and most 
importantly high economic feasibility [3]. Although ole-
aginous microorganisms can natively produce and accu-
mulate high amounts of lipids, production yields, titers, 
and productivities of the wild-type strains hardly meet 
the industrial requirements. Therefore, improving those 
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properties of oleaginous microorganisms has become 
an interesting research topic, and numerous studies on 
metabolic engineering of oleaginous microorganisms 
have recently been published [4–6]. Among the vari-
ous oleaginous microorganisms, Yarrowia lipolytica has 
drawn a great attention as a model oleaginous yeast [7, 
8]. Up until now, several proof-of-concept studies have 
demonstrated that engineered Y. lipolytica strains can be 
an efficient production platform for a variety of fuels and 
oleochemicals [9].
Oleaginous yeasts including Y. lipolytica start to accu-
mulate lipids in response to nutrient depletion. Typically, 
nitrogen-limited conditions are employed to produce 
lipids in oleaginous yeasts, and the general mechanism 
of how nitrogen limitation leads to lipid production had 
been suggested before [10]. The lipid production has 
most commonly been studied in batch cultivation sys-
tems using culture media with high carbon-to-nitrogen 
ratios to conveniently establish nitrogen-limited station-
ary phase conditions. When nitrogen is no longer avail-
able in the media after the exponential growth phase, 
cells cease the growth as they cannot synthesize new 
biomass building blocks, such as amino acids and nucleo-
tides. Instead, the cells start to convert remaining carbon 
sources into storage lipids mainly as triacylglycerides 
(TAGs). The first molecular event known to trigger this 
phenomenon is a decrease in adenosine monophosphate 
(AMP) level in the cells by the action of AMP deaminase 
[11]. Then, the activity of mitochondrial isocitrate dehy-
drogenase, for which AMP is an allosteric regulator, is 
decreased, which in turn causes an accumulation of cit-
rate in the mitochondria [12]. The citrate accumulated 
in the mitochondria is then transported to the cytosol by 
citrate/malate antiporters and subsequently converted 
into cytosolic acetyl-CoA by ATP:citrate lyase [11, 12]. 
Finally, the acetyl-CoA is used for the biosynthesis of 
fatty acyl-CoAs, and the fatty acyl-CoAs are converted 
into TAGs through the Kennedy pathway enzymes [13]. 
However, it has recently been shown that the metabolic 
transition for lipid production is not confined to the 
aforementioned pathways, but rather involves global 
changes across whole transcriptome, proteome, metabo-
lome, and lipidome [14–16]. Therefore, further under-
standing of the lipid production mechanism is required 
for sophisticated design of engineered strains and control 
of the lipid production process.
Systems biology provides essential tools for modern 
biotechnology to effectively design, build, test, and 
learn the engineered microbial strains [17, 18]. Espe-
cially, genome-scale models of metabolism (GEMs) 
together with various constraint-based modeling meth-
ods provide an advanced understanding of microbial 
metabolism [19]. Moreover, in conjunction with the 
development of a number of computational strain opti-
mization methods (CSOMs), GEMs have been success-
fully applied to find novel non-intuitive genetic designs 
for metabolic engineering of various industrial hosts, 
including Escherichia coli and Saccharomyces cerevi-
siae [20]. In an effort to apply such tools for metabolic 
engineering of oleaginous yeasts, several GEMs for ole-
aginous yeasts, especially for Y. lipolytica, have recently 
been developed [21]. The first two GEMs of Y. lipolytica 
(iNL895 [22] and iYL619_PCP [23]) were reported by 
two independent groups in 2012. In those pioneering 
works, the focus was more on reconstruction and char-
acterization of metabolic network of Y. lipolytica than 
on application of GEMs. In 2015 and 2016, two other 
groups published papers on new GEMs of Y. lipolytica, 
iMK735 [24] and iYali4 [25], respectively. The two stud-
ies were more application-oriented than the first two 
studies: iMK735 was used for optimizing fed-batch 
cultivation of the wild-type Y. lipolytica strain for lipid 
production [24], and iYali4 served as a framework for 
integrative analysis of transcriptomic, lipidomic, and 
fermentation profiles to uncover regulation of Y. lipo-
lytica metabolism [25]. The four Y. lipolytica GEMs 
were developed independently based on different scaf-
fold models, resources, and databases (for more details, 
see [21]). Briefly, iNL895 and iYali4 were derived from 
different versions of yeast consensus metabolic network 
for S. cerevisiae [26], iYL619_PCP was assembled from 
biochemical and genomic information in multiple data-
bases such as KEGG [27] and BiGG [28], and iMK735 
was reconstructed using iND750, a high-quality GEM 
of S. cerevisiae [29], as a scaffold. Very recently, Wei 
et  al. [30] and Mishra et  al. [31] explored metabolic 
engineering strategies using updated Y. lipolytica 
GEMs (iYL_2.0 and iYLI647 which are descendants of 
iYL619_PCP and iMK735, respectively) and existing 
CSOMs. Various CSOMs were tested in the two recent 
studies, e.g., OptGeneKnock [32] and APGC [33] for 
TAG production, and tSOT [34] and cofactor modifi-
cation analysis [35] for dodecanedioic acid production; 
however, although they suggested some interesting 
strategies, none of them successfully rediscovered sev-
eral well-known gene targets or led to an experimental 
validation.
Here, we argue that the lack of successful application 
of GEMs for metabolic engineering of Y. lipolytica is 
because there is still a lack of suitable constraint-based 
modeling methods for predicting metabolic behav-
iors of oleaginous yeasts. In particular, when consider-
ing a typical batch culture scenario for lipid production 
using oleaginous yeasts, there is no proper method for 
predicting flux distribution, including lipid produc-
tion rate, in nitrogen-limited condition (i.e., stationary 
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phase of a microbial growth curve). Flux balance analy-
sis (FBA) is the most popular constraint-based modeling 
method for predicting metabolic fluxes using GEMs by 
optimizing an evolutionary objective function [36]. In 
general, using maximization of biomass production as 
an objective function, FBA works nicely for predicting 
flux distribution in exponentially growing cells in non-
limited condition (i.e., log phase of a microbial growth 
curve). However, it is hard to predict the flux distribu-
tion in non-growing cells under the nitrogen-limited 
condition using FBA, since the objective of the cells is 
unclear under such condition. Another obstacle imped-
ing the application of GEMs is a lack of proper CSOMs 
for such case. Although a number of CSOMs which can 
perform a variety of design tasks already exist, majority 
of the CSOMs are developed to find metabolic designs 
which enable growth-coupled production of target 
chemicals [20]. However, the lipid production in oleagi-
nous yeasts in a batch reactor is a non-growth-coupled 
process. Therefore, strain designs predicted by exist-
ing CSOMs for growth-coupled production of lipids are 
likely to fail because they may result in the loss of the 
oleaginous yeasts’ native ability to produce and accumu-
late lipids through the non-growth-coupled process. It 
should be noted that oleaginous yeasts can produce lipids 
in a growth-coupled manner, when they are cultured in 
a nitrogen-limited chemostat [25, 37]; however, we lim-
ited the scope of our work to nitrogen-limited batch cul-
ture scenarios as the batch and chemostat cultures are 
greatly different from each other in many terms, e.g., 
growth phenotype and nitrogen concentration in culture 
medium.
In this work, we demonstrated that minimization of 
metabolic adjustments (MOMA), another very popular 
constraint-based modeling method developed to find a 
flux distribution for a perturbed condition by minimizing 
the Euclidean distance from a reference flux distribution 
[38], can be applied to overcome the obstacles described 
above. While MOMA has been extensively used for ana-
lyzing phenotypic changes in response to genetic per-
turbations, some recent studies showed that MOMA is 
also useful for predicting metabolic alterations following 
environmental or nutritional changes [39–41]. Inspired 
by such reports, after showing that environmental ver-
sion of MOMA (eMOMA) can also be used for predict-
ing phenotypes of Y. lipolytica under nitrogen-limited 
conditions, we applied eMOMA for predicting metabolic 
engineering strategies to improve the lipid production in 
Y. lipolytica. Using our eMOMA-based design method, 
we successfully identified both known and novel genetic 
intervention targets for improving the lipid production 
and experimentally validated the model predictions by 
constructing knockout strains using the recently devel-
oped CRISPR/Cas9 system.
Results and discussion
Predicting phenotypes of Y. lipolytica in nutrient‑limited 
conditions
We implemented eMOMA to predict metabolic fluxes of 
the cells in nutrient-limited conditions. The procedure 
of making eMOMA prediction, which consists of three 
optimization problems, is schematically represented in 
Fig. 1a. The first optimization problem, an FBA problem 
with growth maximization as an objective function, was 
solved to find a maximum specific growth rate (μmax) of 
the cells under non-limited growth conditions. Due to 
the degeneracy of FBA solutions, there are infinite num-
ber of flux vectors which can support the maximum 
specific growth rate [36]. However, MOMA, the main 
component of the eMOMA procedure, requires a par-
ticular flux vector as the reference state [38]. Thus, parsi-
monious FBA (pFBA), which minimizes sum of absolute 
fluxes based on the optimal enzyme usage assumption 
[42], was introduced as the second optimization problem 
to select a biologically plausible flux vector represent-
ing metabolic flux distribution under the non-limited 
growth conditions. Then, the third optimization prob-
lem, which performs actual eMOMA, was formulated 
using the previous pFBA solution as the reference state. 
The final eMOMA solution (solution of the third optimi-
zation problem) should represent an adapted metabolic 
flux distribution in response to the depletion of an essen-
tial nutrient for growth. Here, we hypothesized that the 
eMOMA solution can represent the metabolic flux distri-
bution in the cells under nutrient-limited conditions.
To test whether eMOMA can be used for predicting 
phenotypes of Y. lipolytica in nitrogen-limited condi-
tions, it was applied to a published GEM for Y. lipolytica, 
iMK735 [24]. We used the same in silico glucose mini-
mal medium described by Kavscek et al. [24] for a non-
limited growth condition and blocked the ammonium 
exchange flux for a nitrogen-limited condition.
Firstly, predicted changes in exchange fluxes between 
the non-limited and nitrogen-limited conditions (Fig.  2, 
black and light gray bars) were compared to the known 
Y. lipolytica physiology. Under the non-limited condition, 
the cells consume balanced amounts of glucose, ammo-
nium, phosphate, sulfate, and oxygen to produce bio-
mass. No byproduct production except for tiny amounts 
of zymosterol and inositol was predicted for the cells in 
the non-limited condition. Following the nitrogen star-
vation (applied by the blockage of ammonium uptake), 
consumption and production profiles of nutrients and 
metabolites, respectively, were predicted to completely 
change as the cells could not produce biomass anymore 
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while still consuming the glucose. Most strikingly, 
eMOMA successfully predicted TAG and citrate as the 
major products produced by Y. lipolytica during nitro-
gen limitation, which is the representative characteristic 
of the wild-type Y. lipolytica strains. In addition, produc-
tion of ergosterol was predicted for the nitrogen-limited 
condition as some previous studies had reported [25, 
43]. Furthermore, a reduction of glucose uptake rate in 
the nitrogen-limited condition was predicted in accord-
ance with the previous report [24]. Although eMOMA 
correctly predicted the tendency of metabolic shifts 
in Y. lipolytica following the nitrogen starvation, some 
quantitative discrepancies between the predicted and 
measured exchange fluxes were observed. In the previ-
ous report, it has been shown that 54% and 13.5% of the 
carbon utilized during the nitrogen-limited condition 
were converted into citrate and TAG, respectively [24]. 
However, the eMOMA prediction was only 27% and 2.0% 
for citrate and TAG, respectively. In addition, the pre-
dicted glucose uptake rate during the nitrogen limitation 
(3.0  mmol/g DCW/h) was much higher than the meas-
ured value (0.35  mmol/g DCW/h) [24]. Nevertheless, it 
Fig. 1 Geometric illustration of the eMOMA method. Red‑colored area represents a solution space of flux vectors which can support maximum 
specific growth rate, while blue‑colored area represents a solution space of flux vectors for nutrient‑limited conditions. Upon nutrient starvation, 
the cells cannot retain a flux vector selected by pFBA and should adjust their fluxes from the red‑colored area to the blue‑colored area. eMOMA 
assumes that the cells try to minimize the metabolic adjustments in response to environmental perturbations (represented by black perpendicular 
dotted lines). Illustrations for a wild‑type and b mutant situations are provided
Fig. 2 Exchange fluxes for non‑limited, nitrogen‑limited and phosphate‑limited conditions predicted by eMOMA. Predicted exchange fluxes for 
non‑limited, nitrogen‑limited and phosphate‑limited conditions are shown by black, light gray, and dark gray, respectively. eMOMA was used for 
predicting fluxes for nitrogen‑limited and phosphate‑limited conditions while pFBA was used for predicting fluxes for the non‑limited condition. 
Arrows indicate constraints specifying the limiting nutrients for each condition
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is quite surprising that the GEM, which does not account 
for any regulatory information, could predict the trends 
of metabolic shifts in Y. lipolytica by just using eMOMA. 
This success is somewhat in accordance with the reported 
lack of direct regulatory controls for lipid metabolism in 
response to nitrogen limitation in Y. lipolytica, e.g., no 
significant changes in transcript levels for the genes in 
lipid biosynthetic pathway [25].
In addition to the nitrogen limitation, phosphate limi-
tation is also known to effectively induce lipid accumu-
lation in Rhodosporidium toruloides, another highly 
studied oleaginous yeast [44]. Inspired by the study, we 
also made the flux prediction for a phosphate-limited 
condition using eMOMA (Fig.  2, dark gray bars). Here, 
we blocked the phosphate exchange flux instead of the 
ammonium exchange flux. Predicted exchange fluxes 
for the phosphate-limited condition were somewhat dif-
ferent from those for the nitrogen-limited condition. 
Notably, continuous utilization of ammonium and sub-
sequent production of amino acids were predicted for 
the phosphate-limited condition even though the bio-
mass production was blocked. In contrast, phosphate was 
predicted to no longer be used in the nitrogen-limited 
condition due to a lack of byproducts into which phos-
phorus can be incorporated. Furthermore, production of 
a higher amount of TAG and a significantly lesser amount 
of citrate was predicted for the phosphate-limited condi-
tion. In addition to the fact that several raw feedstocks 
are adequate for establishing phosphate limitation [45], 
the eMOMA results suggest that the phosphate limita-
tion is a promising strategy for the production of lipids in 
Y. lipolytica. Finally, as the fluxes predicted for the nitro-
gen-limited and phosphate-limited conditions were quite 
different, eMOMA prediction is dependent on the type 
of limited nutrients but not a result solely from the block-
age of biomass formation.
To further investigate whether eMOMA can also pre-
dict intracellular fluxes of Y. lipolytica in nitrogen-lim-
ited conditions, we compared eMOMA-predicted fluxes 
with a reported 13C-metabolic flux analysis (MFA) result. 
Recently, Wasylenko et  al. have reported the metabolic 
flux distribution of a Y. lipolytica strain (MTYL037, 
which is similar to the wild-type) in nitrogen-limited 
conditions by parallel labeling experiments [46]. The 
eMOMA-predicted fluxes for the nitrogen-limited con-
dition showed a significant correlation with the 13C-MFA 
flux data (Fig.  3, r = 0.86, p < 10−10). Note that only the 
fluxes for the reactions in the central metabolism were 
compared due to the limited coverage of 13C-MFA (Addi-
tional file 1: Table S1). As shown in Fig. 3, the eMOMA-
predicted and 13C-MFA-estimated fluxes for glycolytic 
pathway reactions showed a high correlation. However, 
the eMOMA-predicted fluxes for pentose phosphate 
pathway reactions were quite lower than the 13C-MFA-
estimated fluxes. Such inaccurate prediction for pentose 
phosphate pathway fluxes might be caused by differences 
in description of NADPH-related pathways between the 
GEM and the metabolic model of central metabolism 
used for 13C-MFA. The differences are due to the fact 
that NADPH metabolism in Y. lipolytica is still unclear 
and remains controversial [47]. More specifically, Y. lipo-
lytica lacks cytosolic malic enzyme, which is known to 
be a major source of NADPH for lipid biosynthesis in 
many other oleaginous fungi, and thus, should have alter-
native sources of NADPH for lipogenesis. The potential 
alternative sources of NADPH include oxidative pen-
tose phosphate pathway (as investigated in the 13C-MFA 
study [46]), cytosolic  NADP+-dependent isocitrate dehy-
drogenase (as discussed in [47]), and others. However, 
for instance, the cytosolic isocitrate dehydrogenase was 
modeled differently in the GEM and the 13C-MFA model, 
i.e., the cytosolic  NADP+-dependent isocitrate dehydro-
genase reaction was included in the GEM but not in the 
13C-MFA model. This could contribute to the lower pen-
tose phosphate pathway fluxes predicted by eMOMA. 
Nevertheless, based on the high overall correlation, we 
concluded that the eMOMA method can predict intra-
cellular fluxes of the cells under nitrogen-limited con-



















Flux estimated by 13C-MFA
Fig. 3 Comparison of fluxes estimated by 13C‑MFA and fluxes 
predicted by eMOMA. The fluxes for nitrogen‑limited conditions 
estimated by 13C‑MFA (best‑fit fluxes for MTYL037 strain calculated 
using an MFA model without cytosolic malic enzyme reaction) 
[46] and predicted by eMOMA have been compared. All fluxes are 
normalized to glucose uptake rate of 1
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of comparing the eMOMA-predicted and 13C-MFA-
estimated fluxes is to demonstrate how eMOMA works 
rather than to make a perfect fit, and this result is not 
based on any deliberate manipulation of the model con-
straints or objective function. To sum up, the exchange 
and intracellular fluxes for the nitrogen-limited condi-
tion predicted by the eMOMA method resembled the 
actual flux distribution (including lipid production) even 
though there existed some quantitative discrepancies.
Predicting metabolic engineering strategies for improved 
lipid production
After confirming that eMOMA can be used for predict-
ing metabolic phenotypes of Y. lipolytica including lipid 
production, we next used the method to design mutant 
strains for improved lipid production. Figure  1b shows 
how eMOMA can be used for searching metabolic engi-
neering strategies. As described in the previous section, 
eMOMA is composed of three optimization problems, 
and the solutions for each optimization problem can be 
changed by the application of new constraints describ-
ing the attributes of mutant strains. In other words, the 
changes in the allowable solution spaces for maximal 
growth and/or nutrient-limited conditions can result in 
the changes in eMOMA solutions. As a result, the lipid 
production rates determined in the final eMOMA solu-
tions can also be changed in some cases.
We employed a brute force approach to find target reac-
tions for overexpression or knockout that may increase 
the lipid production in Y. lipolytica under nitrogen-lim-
ited conditions. Toward this end, we first identified can-
didate reactions which can be genetically overexpressed 
or deleted without significantly harming cell growth (see 
“Materials and methods”). In result, 205 and 304 reac-
tions were selected to be overexpressed and deleted in 
silico, respectively (Additional file 1: Table S2). Then, the 
eMOMA procedure for mutants was conducted for all in 
silico single mutants, and mutations predicted to increase 
the lipid production yield were identified. The top ten 
overexpression and knockout target reactions based on 
predicted yield improvements are listed in Tables 1 and 2, 
respectively. Overall, 40 overexpression and 9 knockout 
target reactions were predicted to increase the lipid pro-
duction by more than 10% (Full list of the overexpression 
targets are available in Additional file 1: Table S3).
Interestingly, several experimentally validated, well-
characterized overexpression targets were successfully 
called by the eMOMA-based design method (Table  1). 
Overexpression of acetyl-CoA carboxylase (ACCOACr) 
and diglyceride acyltransferase (TRIGSY_GLC) was pre-
dicted by the eMOMA-based design method. Though the 
strategy is very basic, it is the most powerful approach for 
improving the lipid production in Y. lipolytica by push-
ing and pulling metabolic fluxes toward lipid biosyn-
thetic pathway [48]. Furthermore, the eMOMA method 
identified delta-9 stearoyl-CoA desaturase (DESAT18) 
as an overexpression target which is also identified as a 
rate-limiting step of lipid biosynthesis in Y. lipolytica by 
a recent reverse engineering study [49]. ATP:citrate lyase 
(ATPCitL), a distinctive enzyme conferring oleaginous 
characteristic, was also identified as an overexpression 
target and it has been shown that the overexpression of 
the enzyme significantly increases the lipid production 
in Y. lipolytica [50]. Along with these experimentally 
validated targets, several reactions which are directly 
involved in the lipogenesis of oleaginous yeasts, such as 
citrate/malate antiporter (CITtam), fatty acyl-CoA syn-
thase (FASn0COA), and citrate synthase (CSm), were 
identified as overexpression targets. Although these tar-
gets seem to be apparent and play similar roles on the 
Table 1 Top ten overexpression targets for increasing lipid production predicted by eMOMA-based design method
Reaction abbreviation Reaction description EC number Genes associated Predicted yield 
improvement 
(%)
CITtam Citrate/malate antiporter (mitochondrial) n/a YALI0F26323g 78.7
TRIGSY_GLC Diglyceride acyltransferase EC 2.3.1.20 (YALI0E16797g or YALI0E32769g) 74.0
ACCOACr Acetyl‑CoA carboxylase EC 6.4.1.2 YALI0C11407g 67.7
FASn0COA Fatty acyl‑CoA synthase (n = 8, 10, 12, 14, 16, 18) EC 2.3.1.86 (YALI0B15059g and YALI0B19382g 
and YALI0C11407g and 
YALI0E23185g)
38.9–56.7
CSm Citrate synthase (mitochondrial) EC 2.3.3.1 (YALI0E00638g or YALI0E02684g) 55.6
DESAT18 Stearoyl‑CoA desaturase EC 1.14.19.1 YALI0C05951g 35.4
ATPCitL ATP:citrate lyase EC 2.3.3.8 (YALI0E34793g and YALI0D24431g) 27.9
HSDxi Homoserine dehydrogenase (NADH) EC 1.1.1.3 YALI0D01089g 21.0
ASADi Aspartate‑semialdehyde dehydrogenase EC 1.2.1.11 YALI0D13596g 21.0
ASPKi Aspartate kinase EC 2.7.2.4 YALI0D11704g 21.0
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production of lipids, the eMOMA prediction provides 
an additional aspect, i.e., the predicted yield improve-
ments for each target. It is notable that the predicted 
yield improvements were not directly related to the dis-
tances from the TAG node in the metabolic pathway map 
or basal flux levels of the reactions. It could be thought 
that the eMOMA prediction reflects complexity of inter-
twined structures of metabolic pathways. Even though it 
was yet to know that the actual lipid production yields 
would meet the predicted tendency at this moment, the 
prediction was still meaningful since it could be used for 
deciding a priority of conducting experiments.
The remaining top ten overexpression targets, i.e., 
homoserine dehydrogenase (HSDxi), aspartate-semial-
dehyde dehydrogenase (ASADi), and aspartate kinase 
(ASPKi), were all involved in the threonine biosynthesis 
(Table 1). At a glance, prediction of these targets did not 
make sense. However, the predicted flux distributions of 
the mutants suggested that overexpression of threonine 
biosynthetic pathway increases the fluxes through TCA 
cycle in the non-limited condition and subsequently in 
the nitrogen-limited condition. The higher activity of 
TCA cycle would provide more citrate to be utilized for 
generating cytosolic acetyl-CoA. From this example, a 
novel strategy for improving lipid production in oleagi-
nous yeasts can be suggested: increase the basal fluxes 
through TCA cycle by manipulating pathways which pull 
out TCA cycle intermediates, e.g., threonine biosynthetic 
pathway.
For the deletion targets, reactions involved in 
one-carbon/methionine metabolism (MTHFC, 
methenyltetrahydrofolate cyclohydrolase; FTHFL, for-
mate-tetrahydrofolate ligase; MTHFD, methylenetet-
rahydrofolate dehydrogenase) and arginine metabolism 
(ALPHNH, allophanate hydrolase; UREASE, urea car-
boxylase; ARGN, arginase) were predicted as top targets 
(Table 2). In the nitrogen-limited condition, as net inflow 
of nitrogen moiety was not allowed, wild-type cells pre-
dicted to run futile cycles of biosynthesis and degrada-
tion of methionine and arginine to maintain a metabolic 
status as close as possible to that for the non-limited 
growth condition. In a biological sense, such futile cycling 
is somewhat plausible as maintaining machineries for the 
biosynthesis of amino acids, even in the nitrogen-limited 
condition, would help the cells quickly restart the growth 
when nitrogen becomes available again. This idea is sup-
ported by a recent proteomic study of Y. lipolytica that 
showed significant upregulation of urea carboxylase and 
arginase in nitrogen-limited conditions [14]. However, 
for the lipid production, such futile cycling that consumes 
substantial energy would not be beneficial at all. In this 
respect, knockouts of these reactions from the futile cycles 
were predicted to block the cycles and redirect the saved 
energy to lipid production.
Rest of the predicted deletion targets were also quite 
interesting (Table  2). Deletion of ergosterol transport 
reaction (ERGSTt) was predicted to redirect acetyl-CoA 
and NADPH used for ergosterol biosynthesis to TAG 
biosynthesis. Such reconstitution of lipid bodies could 
be realized by manipulating diglyceride acyltransferases 
and steryl-ester synthases, which is a more practical way 
than directly controlling the ergosterol biosynthesis, as 
experimentally demonstrated [51]. Meanwhile, knock-
out of glycine hydroxymethyltransferase (GHMT2r) was 
predicted to activate alanine glyoxylate transaminase 
(AGT) as an alternative route to produce glycine. Use of 
the route involving AGT would enhance fluxes through 
citrate and isocitrate in the non-limited growth condition 
and results in higher fluxes through citrate in the nitro-
gen-limited condition, finally leading to an improved 
lipid production. Hence, a rationale for this prediction 
is similar to that for the overexpression of reactions in 
threonine biosynthetic pathway. Lastly, knockout of 
mitochondrial isocitrate dehydrogenase (ICDHym) was 
Table 2 Top ten knockout targets for increasing lipid production predicted by eMOMA-based design method
Reaction 
abbreviation
Reaction description EC number Genes associated Predicted yield 
improvement (%)
MTHFC Methenyltetrahydrofolate cyclohydrolase EC 3.5.4.9 (YALI0F30745g and YALI0E01056g) 57.1
FTHFL Formate‑tetrahydrofolate ligase EC 6.3.4.3 (YALI0E01056g and YALI0F30745g) 51.9
MTHFD Methylenetetrahydrofolate dehydrogenase  (NADP+) EC 1.5.1.5 (YALI0F30745g and YALI0E01056g) 51.1
ALPHNH Allophanate hydrolase EC 3.5.1.54 YALI0E07271g 50.9
UREASE Urea carboxylase EC 6.3.4.6 YALI0E07271g 50.9
ARGN Arginase EC 3.5.3.1 YALI0E07535g 50.9
ERGSTt Ergosterol reversible transport (extracellular) n/a YALI0F17996g 48.0
GHMT2r Glycine hydroxymethyltransferase EC 2.1.2.1 (YALI0D22484g and YALI0E16346g) 15.5
IPPSm 2‑Isopropylmalate synthase (mitochondrial) EC 2.3.3.13 YALI0B07447g 10.7
ICDHym Isocitrate dehydrogenase  (NADP+, mitochondrial) EC 1.1.1.42 YALI0F04095g 9.3
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predicted. Although decrease of mitochondrial isocitrate 
dehydrogenase activity is known to trigger lipid produc-
tion in oleaginous yeasts [12], the effects of knockout or 
repression of the enzyme have not yet been studied.
While our eMOMA-based design method success-
fully rediscovered many experimentally validated targets, 
some well-known knockout targets involved in lipid deg-
radation, such as PEX10 (peroxisome biogenesis factor), 
TGL3 (lipase), and MFE1 (peroxisomal multifunctional 
enzyme type 1), were not identified by the eMOMA-
based design method. This is because we employed pFBA 
for predicting flux distribution of the wild-type strain 
in the non-limited growth condition. As pFBA does 
not allow futile cycles, zero fluxes through lipid/fatty 
acid degradation pathways were predicted for the wild-
type cells in the non-limited condition. Subsequently, 
eMOMA also predicted zero fluxes through such path-
ways for the wild-type cells in the nitrogen-limited condi-
tion. Therefore, knockouts of reactions in such lipid/fatty 
acid degradation pathways were predicted to have no 
effects as the fluxes were already zero in both non-limited 
and nitrogen-limited conditions. On the other hand, top 
targets predicted by the eMOMA-based design method 
did not include the reactions directly related to cofactors 
such as ATP and NADPH, which are keys to lipid pro-
duction. Indeed, strategies like “push and pull” showed 
the most pronounced effects when only the native Y. 
lipolytica metabolism was considered as a design space 
[48, 49]. However, cofactor balancing strategies were 
later turned out to be important for further improving 
the lipid production when synthetic/heterologous path-
ways were also included in the design space [52]. As the 
search space of eMOMA-based design method in this 
study is limited to the native Y. lipolytica metabolism, 
the lack of ATP/NADPH-related targets in the lists is in 
a good agreement with the existing reports. Neverthe-
less, in future studies, it would be interesting to expand 
the search space of eMOMA-based design method, i.e., 
to include synthetic/heterologous pathways in the design 
space, and to see what kinds of new targets could be 
predicted.
Experimental validation of predicted strategies 
by constructing knockout mutants
So far, engineering efforts to improve the lipid production 
in Y. lipolytica have focused primarily on lipid biosynthe-
sis and degradation pathways [52–54]. Our eMOMA-
based design method successfully predicted well-known 
overexpression targets in the lipid biosynthesis pathway, 
such as acetyl-CoA carboxylase, diglyceride acyltrans-
ferase, and delta-9 stearoyl-CoA desaturase, which have 
critical effects on lipid production in Y. lipolytica [49]. 
In contrast, most of the predicted deletion targets were 
not closely located to the lipid biosynthesis and degrada-
tion pathways. Thus, the deletion targets predicted by the 
eMOMA method were novel and non-intuitive. So, we 
wanted to examine whether or not these novel deletion 
targets are indeed effective.
Three genes, YALI0F30745g, YALI0E01056g, and 
YALI0E07271g, which are associated with the top knock-
out target reactions in Table 2, were selected for experi-
mental validation. YALI0F30745g and YALI0E01056g 
encode the same trifunctional enzyme, which may only 
differ in subcellular localization, meditating methe-
nyltetrahydrofolate cyclohydrolase, formate-tetrahy-
drofolate ligase, and methylene-tetrahydrofolate 
dehydrogenase reactions in one-carbon/methionine 
metabolism. YALI0E07271g encodes a urea carboxylase 
catalyzing consecutive reactions in arginine metabolism. 
We employed recently developed CRISPR/Cas9 system to 
construct knockout mutants for the three selected genes. 
We successfully constructed knockout mutants for YAL-
I0F30745g and YALI0E07271g, but failed to obtain the 
knockout mutant for YALI0E01056g. As YALI0E01056g 
is likely to be non-essential as suggested by a very recent 
functional genomics study [55], it is more reasonable 
to assume that the gene could not be properly targeted 
using the genetic engineering tool we choose. Although 
CRISPR/Cas9 systems are known to be highly efficient 
and versatile, some genes are not readily accessible by 
Cas9 for various reasons, e.g., chromatin structure or 
nucleosome occupancy [56]. Indeed, it has been reported 
that some genes in Y. lipolytica are particularly hard to 
manipulate using the CRISPR/Cas9 system [57], and 
YALI0E01056g may belong to such a category of genes. 
Identifying the reason why the attempts to obtain the 
knockout mutant failed may need considerable molecular 
biology works, e.g., gene knockdown experiment using 
RNA interference, which is beyond the scope of this 
work. Therefore, having left the issue for further studies, 
we moved on to culture experiments with the two con-
structed knockout mutants for comparison.
We profiled growth and lipid accumulation of the 
knockout mutants in a batch culture using CN75 
medium and compared them to that of the wild-type 
strain (Fig. 4). CN75 medium was designed to reflect the 
essence of in silico glucose minimal medium which was 
used for making the in silico predictions (see “Materi-
als and methods”). Varying carbon-to-nitrogen ratios 
were tested using the wild-type strain to establish proper 
nitrogen-limited conditions for lipid production in later 
stages of batch culture. Carbon-to-nitrogen ratio of 75 
was selected to yield CN75 medium in which the wild-
type strain showed a high lipid content and fast growth 
(data not shown). When we cultured the knockout 
mutants using CN75 medium, both knockout mutants 
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showed similar growth curves to that of the wild-type 
(Fig.  4a). This result was expected to a certain extent 
because growth defective mutants were removed from 
the beginning of our computational pipeline (see “Mate-
rials and methods”). After 3  days of the culture, the 
YALI0F30745gΔ strain showed 45% increase in lipid 
content compared to the wild-type strain (Fig. 4b; 9.72% 
vs. 6.66% based on g lipid/g DCW). Meanwhile, lipid 
content of the YALI0E07271gΔ strain did not increase 
significantly. Interestingly, fat-free biomass profiles of 
the wild-type and knockout mutants for the first 2 days 
of the culture showed a similar trend (fat-free biomass 
at 48  h: wild-type, 6.30  g/L; YALI0E07271gΔ, 6.38  g/L; 
YALI0F30745gΔ, 6.51  g/L); however, the differences in 
fat-free biomass between the wild-type and the knockout 
mutants were observed at the end of the culture (fat-free 
biomass at 72  h: wild-type, 7.98  g/L; YALI0E07271gΔ, 
6.81 g/L; YALI0F30745gΔ, 6.80 g/L). In other words, dur-
ing the last 24  h of the culture, both knockout mutants 
behaved differently from the wild-type which showed 
a very slow but noticeable stationary phase growth. It 
seems that the knockout mutants shifted their meta-
bolic status to a no-growth state more swiftly than the 
wild-type in response to the nitrogen depletion. This may 
imply that the knockout mutants were more sensitive to 
the nitrogen depletion than the wild-type as the knock-
out mutants were lacking genes in amino acid metabo-
lism. In the case of the YALI0F30745gΔ strain, the early 
metabolic shift seems to have led to the increased lipid 
production. However, in the case of the YALI0E07271gΔ 
strain, the metabolic shift did not occur in favor of 
increased lipid production, even though the gene dele-
tion resulted in a phenotypic change in terms of fat-free 
biomass. To understand why the YALI0E07271gΔ strain 
failed to produce more lipids, high-throughput experi-
ments, such as transcriptomics and metabolomics, could 
be conducted in future studies. In summary, our experi-
mental validation has shown that one of the novel targets 
predicted by the eMOMA method is indeed effective in 
improving the lipid production in Y. lipolytica.
Conclusions
In this study, we showed that metabolic flux distributions 
of Y. lipolytica in nitrogen-limited conditions, which 
cannot be predicted by conventional FBA, could be pre-
dicted by eMOMA. We also demonstrated that eMOMA 
could be further applied to identify metabolic engineer-
ing strategies for improving lipid production in Y. lipol-
ytica. Our eMOMA-based design method successfully 
predicted not only well-known engineering targets but 
also novel and non-intuitive targets. We experimentally 
tested some of the novel knockout targets, and deletion of 
YALI0F30745g in Y. lipolytica showed 1.45-fold increase 
in lipid accumulation compared to the wild-type strain. 
Altogether, eMOMA is a powerful method for identify-
ing metabolic engineering strategies for improved lipid 
production in Y. lipolytica.
There are multiple avenues of further research for 
broadening the applicability of eMOMA-based design 
method. First, although our work was limited to the 
batch culture scenarios, eMOMA could also be applied 
Fig. 4 Growth and lipid accumulation profiles of knockout mutants. Batch culture of wild‑type and knockout mutants was conducted using CN75 
medium for 3 days. Circle, triangle, and rectangular represent wild‑type, YALI0E07271g, and YALI0F30745g knockout mutants, respectively. Growth 
(a) and lipid content (b) curves were obtained with biological replicates
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to chemostat scenarios (e.g., nitrogen-limited chemo-
stat culture) once a method for finding appropriate ref-
erence flux distribution is established for such cases. 
Second, even though our work was focused on the lipid 
production case to clearly demonstrate the effectiveness 
and usefulness of eMOMA-based design method, our 
method could further be applied for predicting metabolic 
engineering strategies for overproducing other chemicals 
if they are also produced in response to nutrient limita-
tion. It would be very interesting if future studies could 
provide experimental validation of newly predicted strat-
egies for production of other chemicals, including fatty 
acid-derived oleochemicals (e.g., fatty alcohols, alka(e)
nes, and esters), terpenoids, and organic acids. Third, 
as more GEMs are becoming available for diverse ole-
aginous microorganisms, the applicability of eMOMA-
based design method could be tested in other oleaginous 
fungi, oleaginous bacteria, and even in oleaginous algae. 
Lastly, expanding the search space of eMOMA-based 
design method, e.g., exploring the effects of multiple 
interventions and synthetic/heterologous pathway intro-





Prior to apply eMOMA to identify flux distribution of 
the cells under nutrient-limited conditions, FBA was 
first utilized to predict flux distribution of the cells under 
non-limited growth conditions which will serve as a ref-
erence state for eMOMA. FBA requires an evolution-
ary objective function, such as maximization of biomass 
production, to simulate flux distribution in the cells [36]. 
Mathematically, FBA is formulated as follows:
subject to
where S is the stoichiometric matrix in which rows rep-
resent metabolites and columns represent reactions, v 
is the flux vector, a is the vector of lower flux bounds, b 
is the vector of upper flux bounds, and c is the vector of 
objective coefficients representing the objective function, 
herein maximization of biomass production. By solving 
this linear programming (LP) problem, a unique opti-
mal value (fopt) for the given objective function, herein 
maximum specific growth rate (μmax), can be obtained 
although there exist a number of flux vectors which sat-




S · v = 0
a ≤ v ≤ b
To further select a particular flux vector to be used as 
a reference state for eMOMA, FBA with parsimonious 
enzyme usage (pFBA; [42]) was employed. The pFBA 
method chooses a flux vector with a minimum sum of 
absolute fluxes, thereby minimizing the total enzyme 
usage, by solving a second LP problem:
subject to
Here, fopt is the optimal value of the objective function 
from the previous LP problem (Eq. 1).
eMOMA
Once the flux distribution for non-limited growth con-
ditions is obtained by pFBA, eMOMA can be used for 
predicting a flux distribution under changed environ-
ments, herein nutrient-limited conditions. The underly-
ing assumption of eMOMA is that the cells subjected to 
environmental challenges, which force the cells cannot 
sustain the established metabolism (i.e., the reference 
state) any longer, try to reallocate metabolic resources as 
minimally as possible with respect to the reference state. 
To account for such behavior, eMOMA for nutrient-lim-
ited conditions was formulated as follows:
subject to
Here, vref is the flux vector for reference state (flux dis-
tribution for non-limited growth conditions) obtained by 
solving the previous pFBA problem (Eq. 2), and vLN,uptake 
is the flux through the uptake reaction of a growth lim-
iting nutrient. Abolition of the essential nutrient uptake 
leads to the cells’ inability to produce biomass. Therefore, 
the cells should redistribute their metabolic fluxes, and 
Eq. (3) searches for the minimal changes in the metabolic 
fluxes.
Designing mutant strains using eMOMA
To design mutant strains with improved lipid (TAG) pro-
duction, aforementioned optimization problems for FBA 
(2)minv |v|
S · v = 0
a ≤ v ≤ b
c · v = fopt
(3)min
v
� v − vref �
S · v = 0
a ≤ v ≤ b
vLN,uptake = 0
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(Eq.  1), pFBA (Eq.  2) and eMOMA (Eq.  3) were solved 
again with the following additional constraints describing 
the attributes of the mutants:
Flux distributions for the mutant strains under nitro-
gen-limited conditions were calculated for each mutant 
by sequentially solving Eqs. (1) (2) and (3) with the new 
constraints in Eq.  (4). Then, fluxes through the TAG 
exchange reaction for wild-type and mutants were com-
pared to find mutants with higher lipid production rates. 
Note that, for simulating overexpression mutants, the 
constraint in Eq.  (4) was applied to only Eqs.  (1) and 
(2) but not to Eq.  (3) to allow an adjustment of the flux 
through the overexpressed reaction in nitrogen-limited 
conditions which could be accomplished by controlling 
levels of metabolites.
Depending on the roles and implicated network struc-
tures of the reactions, manipulation of some reactions 
could exert severe damages to the cell growth. Since the 
fast cell growth is a prerequisite for high lipid produc-
tivities, we only sought for the reaction manipulations 
which can sustain specific growth rates more than 90% 
of that of the wild-type. In addition, by default, twofold 
increased fluxes were constrained for simulating overex-
pression mutants (Eq. 4). However, some reactions could 
not retain twofold increased fluxes without harming cell 
growth. For such reactions, we adjusted the flux fold 
changes for overexpression (between 1.1- and 2-fold) to 
meet the criteria of 90% of growth rate of the wild-type. 
Finally, the reactions which cannot be modulated by 
genetic engineering, i.e., orphan and exchange reactions, 
were excluded from the analysis.
Model and simulation conditions
iMK735 [24], a GEM for Y. lipolytica, was used for this 
study. Although the quality of the model is reasonably 
fair, the model has many loops and lacks some important 
genes for the lipid production pathway which might lead 
to significant prediction errors for our case. Therefore, we 
slightly modified iMK735 to remove the loops and revise 
several apparent errors. The MATLAB code for revising 
iMK735 is provided in Additional file 1: Methods.
For all the simulations, default biomass equation (“bio-
mass_013” reaction, a biomass equation with 1.3% TAG 
content) in iMK735 was used without any modifications. 
Even exponentially growing Y. lipolytica cells in a non-
limited growth condition possess a small amount of TAG 
in their biomass, and such growth-associated production 
of TAG was modeled in the biomass equation [24]. The 
biomass equation can be regarded as “storage-fat-free” 
biomass equation assuming that the TAG contained in 
(4)vtarget =
{
2 · vreftarget, (Overexpression)
0, (Knockout)
the equation is a part of the structural lipids. Then, we 
assumed that the composition of storage-fat-free bio-
mass is constant over the batch culture and introduced a 
demand reaction for TAG to model TAG accumulation in 
a nutrient-limited condition. This is a standard approach 
used to allow the accumulation of a compound in steady-
state models [58]. In summary, TAG accumulation as a 
storage lipid in the nutrient-limited condition was mod-
eled using the demand reaction for TAG rather than the 
biomass equation.
Default ATP maintenance costs in iMK735 were used 
for all the simulations. Following the standard [58], 
growth-associated maintenance energy (GAM) and non-
growth-associated maintenance energy (NGAM) were 
modeled separately in iMK735. GAM was included in 
the biomass equation, and NGAM was modeled using a 
separated ATP hydrolysis reaction (“ATPM”). Note that 
GAM was applied to only non-limited growth condi-
tion (i.e., GAM was not effective in nutrient-limited no-
growth condition because the biomass flux was zero), 
while NGAM was applied to both non-limited and nutri-
ent-limited conditions.
All the simulations were performed using COBRA 
Toolbox v2.0 for MATLAB [59] and in-house imple-
mentation of eMOMA. CPLEX (IBM Inc.) through the 
CPLEXINT MATLAB interface (https ://peopl e.ee.ethz.
ch/~cohys ys/cplex int.html) and Gurobi (Gurobi Optimi-
zation) were used as optimization solvers.
Experimental parts
Strains and growth conditions
Escherichia coli DH5α and Y. lipolytica Po1g ku70∆ 
were used in this study. E. coli DH5α was used for vec-
tor construction for genetic manipulation of Y. lipolytica. 
Y. lipolytica Po1g ku70∆ strain was a generous gift from 
Professor Matthew Wook Chang in National University 
of Singapore. Strains used in this study are listed in Addi-
tional file 1: Table S4.
For non-selective cultivation of Y. lipolytica, YPD 
medium containing glucose 2%, peptone 2%, and yeast 
extract 1% was used. Desired genotype of Y. lipolytica 
was selected or enriched in SD media containing glucose 
2%, Yeast Nitrogen Base without amino acids 6.8 g/L, and 
430 mg/L of amino acids and nucleotide mixture without 
appropriate amino acids for selection. CN75 medium, a 
minimal medium to induce lipid accumulation in Y. lipo-
lytica, was composed of glucose 4%, ammonium sulfate 
1 g/L, and 1.7 g/L of Yeast Nitrogen Base without ammo-
nium sulfate and amino acids. To measure growth and 
lipid accumulation of the knockout mutants in CN75 
medium, the cells were first inoculated in the SD medium 
for seed culture and grown for 2 days at 30 °C. Then, the 
inoculums from the seed culture washed with CN75 
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medium once were added to 50 mL of CN75 medium in 
250 mL baffled flask to give an initial  OD600 = 0.1. Flask 
culture was performed for 3  days. All the experiments 
were performed in biological duplicates.
Construction of knockout mutants
CRISPR/Cas9 system was applied to Y. lipolytica to con-
struct the knockout mutants more easily and rapidly. We 
used Y. lipolytica Po1g ku70∆ strain to avoid non-homolo-
gous end joining [60] and referred this strain as “wild-type”. 
To apply CRISPR/Cas9 system, pCRISPRyl (#70007), a 
plasmid containing codon-optimized Cas9 for Y. lipolytica, 
gRNA scaffold, and auxotrophic marker were purchased 
from Addgene [61]. Then, single-guide RNAs targeting 
each gene of interest were designed using “The ATUM 
gRNA Design Tool” (https ://www.atum.bio/eComm erce/
cas9/input ) and cloned into pCRISPRyl. Primers used in 
this study are listed in Additional file 1: Table S4.
Constructed plasmids for gene deletion and relevant 
editing templates for HR were transformed into Y. lipo-
lytica cells. Cells and DNAs were mixed with a buffer 
containing 45% of PEG 4000, 100  mM of dithiothreitol, 
0.1 M of lithium acetate pH 6.0, and 0.2 μg/μL of single 
strand carrier DNA purchased from ThermoFisher Sci-
entific. The mixture was incubated in 37 °C water bath for 
1 h and plated on selective agar plates.
Lipid analysis
Quantification of neutral lipids in Y. lipolytica was 
described elsewhere. Lipids accumulated in Y. lipolytica 
were first transesterificated into fatty acid methyl esters 
(FAMEs) via acid-catalyzed methanolysis [48]. In short, a 
weighted biomass was lyophilized for a day and then sub-
jected to lipid extraction using 1 mL of chloroform:MeOH 
(2:1) mixture. In this step, for accurate quantification of 
FAMEs, methyl heptadecanoate was used as an inter-
nal standard and added to the extraction solution. After 
vigorous vortexing for an hour, 500 μL of extracted sam-
ple was transferred to 125 μL of saline solution and vor-
texed briefly. Then, chloroform layer was harvested and 
evaporated for further transesterification step. For trans-
esterification, the lipid extract was dissolved in 1  mL of 
2% sulfuric acid in MeOH and incubated at 60 °C for 2 h. 
Then, samples were partially evaporated, and transesterif-
icated FAMEs were extracted by adding 500 μL of hexane. 
1 μL of the extract was subjected to gas chromatography/
mass spectrometry (GC/MS) analysis.
Quantification of the extracted FAMEs was performed 
using Trace GC Ultra system coupled to an ion trap mass 
detector ITQ 1100 (Thermo Scientific, Waltham, MA, 
USA). The transesterificated samples were analyzed using 
a non-polar capillary column (5% phenyl methyl siloxane 
capillary 30  m × 250  μm i.d., 0.25  μm film thicknesses) 
and a linear temperature gradient (60 °C 1 min, temper-
ature gradient of 15  °C/min to 180  °C, hold for 10 min, 
temperature gradient of 15  °C/min to 200  °C, hold for 
10  min, temperature gradient of 15  °C/min to 250  °C, 
hold for 10  min). Standard curves for each FAME were 
obtained using analytic standards purchased from Sigma-
Aldrich Chemical Co. (St. Louis, MO, USA).
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